Listed

HCA Healthcare, Inc.

HCANYSECIK 860730HealthcareFiscal year ends Dec 31

Reports and events: 370 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

HCA Healthcare, Inc., Reports and events
FiledFormWhat it isAccession number
2018-07-2509:01 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-18-225315
2018-05-0816:37 ET10-QQuarterly reportPeriod 2018-03-310001193125-18-156060
2018-05-0217:03 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results0001193125-18-148854
2018-05-0109:16 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-18-145298
2018-04-0516:41 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-18-108801
2018-03-1616:31 ETDEF 14AProxy statementPeriod 2018-04-260001193125-18-085892
2018-03-1317:06 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001193125-18-080824
2018-02-2316:41 ET10-KAnnual reportPeriod 2017-12-310001193125-18-056057
2018-01-3009:01 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-18-024575
2018-01-1716:41 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-18-012244
2017-12-2116:41 ET8-K5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001193125-17-376567
2017-11-0716:21 ET10-QQuarterly reportPeriod 2017-09-300001193125-17-335751
2017-10-3109:05 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-17-326056
2017-10-1816:52 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-17-312708
2017-08-0416:35 ET10-QQuarterly reportPeriod 2017-06-300001193125-17-248794
2017-07-2508:57 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-17-234467
2017-06-3016:50 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001193125-17-220147
2017-06-2216:37 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001193125-17-210508
2017-06-0916:28 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-17-200118
2017-05-0917:04 ET10-QQuarterly reportPeriod 2017-03-310001193125-17-164353
2017-05-0208:55 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-17-153058
2017-04-2816:42 ET8-K5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-17-148482
2017-04-1708:50 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-17-125294
2017-04-0317:08 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-17-108689
2017-03-2016:32 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001193125-17-089394
2017-03-1716:46 ETDEF 14AProxy statementPeriod 2017-04-270001193125-17-087449
2017-02-2217:15 ET10-KAnnual reportPeriod 2016-12-310001193125-17-052253
2017-02-1517:14 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001193125-17-045415
2017-01-3108:56 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-17-024683
2017-01-0908:50 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-17-005220
2016-12-0916:41 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001193125-16-789750
2016-11-1609:26 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-16-769437
2016-11-1519:17 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-16-768058
2016-11-0316:21 ET10-QQuarterly reportPeriod 2016-09-300001193125-16-758862
2016-10-2709:01 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-16-748835
2016-08-1516:59 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001193125-16-682009
2016-08-0917:11 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001193125-16-676933
2016-08-0416:32 ET10-QQuarterly reportPeriod 2016-06-300001193125-16-671884
2016-07-2809:00 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-16-661301
2016-05-1616:50 ET8-K5.02 Departure or appointment of officers or directors0001193125-16-591995
2016-05-1108:31 ET8-K8.01 Other events0001193125-16-586452
2016-05-0617:16 ET10-QQuarterly reportPeriod 2016-03-310001193125-16-582196
2016-05-0316:44 ET8-K5.07 Shareholder vote results0001193125-16-575110
2016-05-0309:01 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-16-573923
2016-04-0116:53 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-16-528048
2016-03-1816:46 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001193125-16-510438
2016-03-1716:31 ETDEF 14AProxy statementPeriod 2016-04-280001193125-16-508623
2016-03-1516:54 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001193125-16-505299
2016-03-0416:31 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001193125-16-493437
2016-02-2616:56 ET10-KAnnual reportPeriod 2015-12-310001193125-16-482165

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 11, 2026, 03:15 ET. Listed shows no prices and gives no investment advice.